Andreas Stadlbauer
Overview
Explore the profile of Andreas Stadlbauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1208
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stadlbauer A, Nikolic K, Oberndorfer S, Marhold F, Kinfe T, Meyer-Base A, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539436
The mutational status of the isocitrate dehydrogenase () gene plays a key role in the treatment of glioma patients because it is known to affect energy metabolism pathways relevant to...
2.
Kipele M, Buchfelder M, Taudte R, Stadlbauer A, Kinfe T, Bozhkov Y
Diagnostics (Basel)
. 2023 Nov;
13(21).
PMID: 37958242
: Metabolomics has growing importance in the research of inflammatory processes. Chronic subdural hematoma (cSDH) is considered to be, at least in part, of inflammatory nature, but no metabolic analyses...
3.
Meyer-Baese A, Jutten K, Meyer-Baese U, Amani A, Malberg H, Stadlbauer A, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345051
Previous studies suggest that the topological properties of structural and functional neural networks in glioma patients are altered beyond the tumor location. These alterations are due to the dynamic interactions...
4.
Barany L, Hore N, Stadlbauer A, Buchfelder M, Brandner S
Diagnostics (Basel)
. 2023 Mar;
13(5).
PMID: 36900055
Introduction: Tractography is an invaluable tool in the planning of tumor surgery in the vicinity of functionally eloquent areas of the brain as well as in the research of normal...
5.
Stadlbauer A, Meyer-Base A
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831407
Artificial intelligence (AI) is considered one of the core technologies of the Fourth Industrial Revolution that is currently taking place [...].
6.
Stadlbauer A, Heinz G, Marhold F, Meyer-Base A, Ganslandt O, Buchfelder M, et al.
Metabolites
. 2022 Dec;
12(12).
PMID: 36557302
Glioblastoma (GB) and brain metastasis (BM) are the most frequent types of brain tumors in adults. Their therapeutic management is quite different and a quick and reliable initial characterization has...
7.
Regensburger M, Chaudhry S, Yasin H, Zhao Y, Stadlbauer A, Buchfelder M, et al.
Brain Behav Immun
. 2022 Sep;
107:53-61.
PMID: 36150585
An increasing body of experimental evidence implicates a relationship between immunometabolic deterioration and the progression of Parkinson's disease (PD) with a dysregulation of central and peripheral neuroinflammatory networks mediated by...
8.
Kinfe T, Del Vecchio A, Nussel M, Zhao Y, Stadlbauer A, Buchfelder M
Expert Rev Neurother
. 2022 Jun;
22(9):781-788.
PMID: 35766355
Introduction: Huntington's Disease as progressive neurological disorders associated with motor, behavioral, and cognitive impairment poses a therapeutic challenge in case of limited responsiveness to established therapeutics. Pallidal deep brain stimulation...
9.
Stadlbauer A, Marhold F, Oberndorfer S, Heinz G, Buchfelder M, Kinfe T, et al.
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35625967
The precise initial characterization of contrast-enhancing brain tumors has significant consequences for clinical outcomes. Various novel neuroimaging methods have been developed to increase the specificity of conventional magnetic resonance imaging...
10.
Nussel M, Zhao Y, Knorr C, Regensburger M, Stadlbauer A, Buchfelder M, et al.
Pain Ther
. 2022 Apr;
11(2):459-476.
PMID: 35471626
Chronic pain (CP) represents a socio-economic burden for affected patients along with therapeutic challenges for currently available therapies. When conventional therapies fail, modulation of the affective pain matrix using reversible...